MedPath

To study the status of illness in children under 5 years and to study the effect of Swarnaprashan in reducing the frequency of illnesses by improving the immunity and increasing the body strength.

Phase 2
Completed
Conditions
Health Condition 1: Y998- Other external cause status
Registration Number
CTRI/2019/04/018759
Lead Sponsor
ational Institute of Ayurveda Jaipur Rajasthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Children with recurrent respiratory infections.

2. Children with recurrent G.I.T. diseases.

3. Children with other recurrent diseases

Exclusion Criteria

1. Subjects suffering from major systemic illness necessitating long term treatment.

2. Subjects with evidence of malignancy.

3. Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S.creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients)

4. Co-morbidity like TB, UTI and bleeding disorders etc.

5. H/o hypersensitivity to any of the trial drug or their ingredients.

6. Subjects who have completed participation in any other clinical trial during the past six months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study the demographic status of morbidity in children under 5 years in a defined population.Timepoint: 4 Weeks
Secondary Outcome Measures
NameTimeMethod
1.To decrease the morbidity status in children with trial drug. <br/ ><br>2.To study the immunomodulatory effect of Swarna prashan. <br/ ><br>Timepoint: 4 Weeks
© Copyright 2025. All Rights Reserved by MedPath